Keeping the GINA in the bottle: Assessing the current need for genetic non-discrimination legislation in Canada

Open Medicine

Volumn 4, Issue 2, 2010, Pages

  Pullman, Daryl ^a   Lemmens, Trudo ^b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956019021     PISSN: None     EISSN: 19112092     Source Type: Journal    
DOI: None     Document Type: Note

References (18)

1. Hudson KL, Holohan MK, Collins FS. Keeping pace with the times-the Genetic Nondiscrimination Act of 2008. N Engl J Med 2008;358(25):2661-2663.
2. Rothstein MA. Putting the Genetic Information Nondiscrimination Act in context. Genet Med 2008;10(9):655-656.
3. Bombard Y, Veenstra G, Friedman JM, Creighton S, Currie L, Paulsen JS, et al. Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey. BMJ 2009;338;b2175.
4. Knoppers BM, Joly Y; Canadian Genetics and Life Insurance Task Force. Physicians, genetics and life insurance. CMAJ 2004;170(9):1421-1423.
5. Greely HT. Banning genetic discrimination. N Engl J Med 2005;353(9):865-867.
6. Abiola S. Recent developments in health law. The Genetic Information Nondiscrimination Act of 2008: "First major Civil Rights bill of the century" bars misuse of genetic test results. J Law Med Ethics 2008;36(4):856-860.
7. Lemmens T. Selective justice, genetic discrimination, and insurance: should we single out genes in our laws? McGill Law J 2000;45(2):347-412.
8. Erwin C. Legal update: living with the Genetic Information Nondiscrimination Act. Genet Med 2008:10(12):869-873.
9. Iglehart JK. Historic Passage-Reform At Last. N Engl J Med 2010;362(14)e48.
10. Flood CM, Roach K, Sossin L, editors. Access to Care, Access to Justice: The Legal Debate over Private Health Insurance in Canada. Toronto: University of Toronto Press; 2005.
11. Blomqvist A, Xu J. Pharmacare in Canada: Issues and Options. Health Canada Working Paper Series (Working Paper 01-01). September 2001. Available: http://www.hc-sc.gc.ca/sr-sr/alt_formats/hpb-dgps/pdf/pubs/hpr-rps/wp-dt/2001-0101-pharma-med/2001-0101-phrama-med-eng.pdf
12. Kuttner R. Market-based failure-a second opinion on U.S. health care costs. NEJM 2008;358(6):549-551.
13. Kamerow D. Yankee Doodling. Our perfectly designed US healthcare system. BMJ 2008;337:a2702.
14. Lemmens T, Lacroix M, Mykitiuk R. Reading the future? Legal and Ethical Challenges of Predictive Genetic Testing. Cowansville: Les Éditions Thémis; 2007.
15. Van Hoyweghen I, Horstman K. European practices of genetic information and insurance: lessons for the Genetic Information Nondiscrimination Act. JAMA 2008;300(3):326-327.
16. Ontario Law Reform Commission. Report on genetic testing. Toronto: The Commission; 1996.
17. Knoppers BM, Lemmens T, Godard B, Joly Y, Avard D, Clark T, et al. Genetics and life insurance in Canada: points to consider. CMAJ 2004;170(9):Online-1-Online-3.
18. Lemmens T. Genetics and insurance discrimination: comparative legislative, regulatory and policy developments and Canadian options. Health Law J 2003;Special SUPPLEMENT:41-86.